0.00Open0.05Pre Close0 Volume87 Open Interest71.00Strike Price0.00Turnover934.70%IV9.15%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0839Delta0.1192Gamma1562.00Leverage Ratio-73.7112Theta0.0000Rho-131.13Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet